Lacktman Quoted on Proposed Registration Process for Telemedicine Prescriptions

Partner Nate Lacktman was quoted in an mHealth Intelligence article, “DEA Launches Registration Process for Prescriptions by Telemedicine,” about a long-awaited Justice Department proposal to create a special registration process that would allow health care providers to use telemedicine to prescribe controlled substances.

Lacktman, chair of the firm’s national Telemedicine & Digital Health Industry Team, has long called for such a move, the article pointed out, quoting from a blog post he co-authored in 2018 in which he said that existing regulations “fail to account for how legitimate telemedicine services are delivered today.”